Serotonin and impulsive aggression

CNS Spectrums

Volumn 20, Issue 3, 2015, Pages 295-302

  Coccaro, Emil F ^a   Fanning, Jennifer R ^a   Phan, K Luan ^b,c,d   Lee, Royce ^a  

^a The University of Chicago   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Aggression; neuroimaging; neurotransmitters; receptors; serotonin

Indexed keywords

FENFLURAMINE; FLUOXETINE; LORCASERIN; MOOD STABILIZER; NEUROLEPTIC AGENT; NEUROTRANSMITTER; PLACEBO; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SEROTONIN RECEPTOR AFFECTING AGENT;

AGGRESSION; BEHAVIOR; BRAIN REGION; HUMAN; IMPULSIVE AGGRESSION; IMPULSIVENESS; MALADJUSTMENT; MEDICAL RESEARCH; METHODOLOGY; NERVE CELL NETWORK; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUICIDAL BEHAVIOR; DRUG EFFECTS; PHYSIOLOGY; SUICIDAL IDEATION;

AGGRESSION; HUMANS; IMPULSIVE BEHAVIOR; SEROTONIN; SEROTONIN AGENTS; SUICIDAL IDEATION;

EID: 84929751252     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852915000310     Document Type: Review

References (70)

1. Dodge KA. The structure and function of reactive and proactive aggression. In: Peppler D, Rubin K eds. The Development and Treatment of Childhood Aggression. Hillsdale, NJ: Erlbaum; 1991: 201-218.
2. Coccaro EF. Intermittent explosive disorder as a disorder of impulsive aggression for DSM-5. Am J Psychiatry. 2012; 169(6): 577-588.
3. Berman ME, Fallon AE, Coccaro EF. The relationship between personality psychopathology and aggressive behavior in research volunteers. J Abnorm Psychol. 1998; 107(4): 651-658.
4. Kessler RC, Coccaro EF, Fava M, Jaeger S, Jin R, Walters E. The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006; 63(6): 669-678.
5. Yanowitch R, Coccaro EF. The neurochemistry of human aggression. Adv Genet. 2011; 75: 151-169.
6. Coccaro EF, Kavoussi RJ, Hauger RL, Cooper TB, Ferris CF. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch Gen Psychiatry. 1998; 55(8): 708-714.
7. Coccaro EF, Lee R, Liu T, Mathé AA. CSF NPY correlates with aggression in human subjects. Biol Psychiatry. 2012; 72(12): 997-1003.
8. Coccaro EF, Lee R, Owens MJ, Kinkead B, Nemeroff CB. Cerebrospinal fluid substance P-like immunoreactivity correlates with aggression in personality disordered subjects. Biol Psychiatry. 2012; 72(3): 238-243.
9. Coccaro EF, Lee R, Vezina P. Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects. J Psychiatr Res. 2013; 47(9): 1247-1253.
10. Coccaro EF, Lee R, Coussons-Read M. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry. 2014; 71(2): 158-165.
11. Asberg M, Schalling D, Traskman-Bendz L, Wagner A. Psychobiology of suicide, impulsivity, and related phenomena. In Davis K ed Psychopharmacology: The Third Generation of Progress. New York: Raven Press; 1987: 665-668.
12. Bourne HR, Bunney WE, Colburn RW, et al. Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid hindbrains of suicidal patients. Lancet. 1968; 2(7572): 805-808.
13. Pare CMB, Yeung DPH, Price K, Stacey RS. 5-Hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning. Lanset. 1969; 2(7612): 133-135.
14. Shaw DM, Eccleston EG, Camps FE. 5-Hydroxytryptamine in the hind-brain of depressive suicides. Br J Psychiatry. 1967; 113(505): 140-1411.
15. Stanley M, Traskman-Bendz L, Dorovini-Zis K. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci. 1985; 37(14): 1279-1286.
16. Asberg M, Träskman L, Thorén P. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry. 1976; 33(10): 1193-1197.
17. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979; 1(2): 131-139.
18. Brown GL, Ebert MH, Goyer PF, et al. Aggression, suicide, and serotonin: relationships to CSF aminemetabolites. Am J Psychiatry. 1982; 139(6): 741-746.
19. Lidberg L, Tuck JR, Asberg M, Scalia-Tomba GP, Bertilsson L. Homicide, suicide, and CSF 5-HIAA. Acta Psychiatr Scand. 1985; 71(3): 230-236.
20. Lester D. The concentration of neurotransmitter metabolites in cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry. 1995; 28(2): 45-50.
21. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry. 1997; 154(10): 1430-1435.
22. Coccaro EF, Kavoussi RJ, Trestman RL, Gabriel SM, Cooper TB, Siever LJ. Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res. 1997; 73(1-2): 1-14.
23. Hibbeln JR, Umhau JC, George DT, Shoaf SE, Linnoila M, Salem N Jr. Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotransmitter metabolites: implications for the biophysical role of highly unsaturated fatty acids. Am J Clin Nutr. 2000; 71(1 Suppl): 331S-338S.
24. Simeon D, Stanley B, Frances A, Mann JJ, Winchel R, Stanley M. Self-mutilation in personality disorders: psychological and biological correlates. Am J Psychiatry. 1992; 149(2): 221-226.
25. Coccaro EF, Lee R. Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: reciprocal relationships with impulsive aggression in human subjects. J Neural Transm. 2010; 117(2): 241-248.
26. Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry. 1989; 46(7): 587-599.
27. Coccaro EF, Lee R, Kavoussi RJ. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects. Neuropsychopharmacology. 2010; 35(2): 435-444.
28. Suarez EC, Krishnan KR. The relation of free plasma tryptophan to anger, hostility, and aggression in a nonpatient sample of adult men and women. Ann Behav Med. 2006; 31(3): 254-260.
29. Goveas JS, Csernansky JG, Coccaro EF. Platelet serotonin content correlates inversely with life history of aggression in personalitydisordered subjects. Psychiatry Res. 2004; 126(1): 23-32.
30. Coccaro E, Kavoussi R, Sheline Y, Lish J, Csernansky J. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch Gen Psychiatry. 1996; 53(6): 531-536.
31. Coccaro EF, Kavoussi RJ, Sheline YI, Berman ME, Csernansky JG. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding. Neuropsychopharmacology. 1997; 16(3): 211-216.
32. Coccaro EF, Lee R, Kavoussi RJ. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder. J Psychiatr Res. 2009; 44(3): 137-142.
33. Marseille R, Lee R, Coccaro EF. Inter-relationship between different platelet measures of 5-HT and their relationship to aggression in human subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 36(2): 277-281.
34. New AS, Trestman RL, Mitropoulou V, et al. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Res. 1997; 69(1): 17-26.
35. Paris J, Zweig-Frank H, Kin NM, Schwartz G, Steiger H, Nair NP. Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. Psychiatry Res. 2004; 121(3): 239-252.
36. O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG. Blunted prolactin responses to d-fenfluramine in sociopathy: evidence for subsensitivity of central serotonergic function. Br J Psychiatry. 1992; 160(5): 643-646.
37. Moeller FG, Steinberg JL, Petty F, et al. Serotonin and impulsive/aggressive behavior in cocaine dependent subjects. Prog Neuropsychopharmacol Biol Psychiatry. 1994; 18(6): 1027-1035.
38. Moss HB, Yao JK, Panzak GL. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry. 1990; 28(4): 325-338.
39. Coccaro EF, Berman ME, Kavoussi RJ, Hauger RL. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personalitydisordered men. Biol Psychiatry. 1996; 40(3): 157-164.
40. Moeller FG, Allen T, Cherek DR, Dougherty DM, Lane S, Swann AC. Ipsapirone neuroendocrine challenge: relationship to aggression as measured in the human laboratory. Psychiatry Res. 1998; 81(1): 31-38.
41. Pihl RO, Young SN, Harden P, Plotnick S, Chamberlain B, Ervin FR. Acute effect of altered tryptophan levels and alcohol on aggression in normal human males. Psychopharmacology (Berl). 1995; 119(4): 353-360.
42. Cleare AJ, Bond AJ. The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects. Psychopharmacology (Berl). 1995; 118(1): 72-81.
43. Dougherty DM, Bjork JM, Marsh D, Moeller FG. Influence of trait hostility on tryptophan depletion-induced laboratory aggression. Psychiatry Res. 1999; 88(3): 227-232.
44. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 1983; 33(26): 2609-2614.
45. Spoont MR. Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol Bull. 1992; 112(2): 330-350.
46. Linnoila VM, Virkkunen M. Aggression, suicidality, and serotonin. J Clin Psychiatry. 1992; 53(Suppl): 46-51.
47. Coccaro EF, Kavoussi RJ, Lesser JC. Self-and other-directed human aggression: the role of the central serotonergic system. Int Clin Psychopharmacol. 1992; 6(Suppl 6): 70-83.
48. Berman ME, McCloskey MS, Fanning JR, Schumacher JA, Coccaro EF. Serotonin augmentation reduces response to attack in aggressive individuals. Psychol Sci. 2009; 20(6): 714-720.
49. Marks DJ, Miller SR, Schulz KP, Newcorn JH, Halperin JM. The interaction of psychosocial adversity and biological risk in childhood aggression. Psychiatry Res. 2007; 151(3): 221-230.
50. Duke AA, Bègue L, Bell R, Eisenlohr-Moul T. Revisiting the serotonin-aggression relation in humans: a meta-analysis. Psychol Bull. 2013; 139(5): 1148-1172.
51. Cleare AJ, Bond AJ. Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression. Psychopharmacology (Berl). 2000; 148(4): 344-349.
52. Almeida M, Lee R, Coccaro EF. Cortisol responses to ipsapirone challenge correlate with aggression, while basal cortisol levels correlate with impulsivity, in personality disorder and healthy volunteer subjects. J Psychiatr Res. 2010; 44(14): 874-880.
53. Bortolato M, Pivac N, Muck Seler D, Nikolac Perkovic M, Pessia M, Di Giovanni G. The role of the serotonergic system at the interface of aggression and suicide. Neuroscience. 2013; 236: 160-185.
54. Olivier B, van Oorschot R. 5-HT1B receptors and aggression: a review. Eur J Pharmacol. 2005; 526(1-3): 207-217.
55. Meyer JH, Wilson AA, Rusjan P, et al. Serotonin2A receptor binding potential in people with aggressive and violent behaviour. J Psychiatry Neurosci. 2008; 33(6): 499-508.
56. Soloff PH, Price JC, Mason NS, Becker C, Meltzer CC. Gender, personality, and serotonin-2A receptor binding in healthy subjects. Psychiatry Research: Neuroimaging. 2010; 181(1): 77-84.
57. Rosell DR, Thompson JL, Slifstein M, et al. Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol Psychiatry. 2010; 67(12): 1154-1162.
58. Siever LJ, Buchsbaum MS, New AS, et al. d, l-fenfluramine response in impulsive personality disorder assessed with [18F] fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology. 1999; 20(5): 413-423.
59. New AS, Hazlett EA, Buchsbaum MS, et al. Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry. 2002; 59(7): 621-629.
60. New AS, Buchsbaum MS, Hazlett EA, et al. Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl). 2004; 176(3-4): 451-458.
61. Leyton M, Okazawa H, Diksic M, et al. Brain regional alpha-[11C] methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry. 2001; 158(5): 775-782.
62. Frankle WG, Lombardo I, New AS, et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry. 2005; 162(5): 915-923.
63. Koch W, Schaaff N, Pöpperl G, et al. [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. J Psychiatry Neurosci. 2007; 32(4): 234-240.
64. Coccaro EF, Lee R, Kavoussi RJ. A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. J Clin Psychiatry. 2009; 70(5): 653-662.
65. George DT, Phillips MJ, Lifshitz M, et al. Fluoxetine treatment of alcoholic perpetrators of domestic violence: a 12-week, doubleblind, randomized, placebo-controlled intervention study. J Clin Psychiatry. 2011; 72(1): 60-65.
66. Silva H, Iturra P, Solari A, et al. Fluoxetine response in impulsiveaggressive behavior and serotonin transporter polymorphism in personality disorder. Psychiatr Genet. 2010; 20(1): 25-30.
67. Heiligenstein JH, Coccaro EJ, Potvin JH, Beasley CM, Dornseif BE, Mascia DN. Fluoxetine not associated with increased violence or aggression in controlled clinical trials. Ann Clin Psychiatry. 1992; 4(4): 285-295.
68. Salzman C, Wolfson AN, Schatzberg A, et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol. 1995; 15(1): 23-29.
69. Coccaro EF, Kavoussi RJ, Hauger RL. Serotonin function and antiaggressive response to fluoxetine: a pilot study. Biol Psychiatry. 1997; 42(7): 546-552.
70. Coccaro EF, Sripada CS, Yanowitch RN, Phan KL. Corticolimbic function in impulsive aggressive behavior. Biol Psychiatry. 2011; 69(12): 1153-1159.